Maxcyte annual current ratio
2020
2021
2022
2023
2024
2025
Maxcyte Current Ratio Growth & History (MXCT)
Maxcyte's current ratio was 8.30 for fiscal 2025.
View full Maxcyte company overviewMaxcyte annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 8.30 | −2.59 | −23.77% |
| 2024 | 2024-12-31 | 10.88 | 0.23 | +2.17% |
| 2023 | 2023-12-31 | 10.65 | −5.70 | −34.86% |
| 2022 | 2022-12-31 | 16.35 | −0.96 | −5.56% |
| 2021 | 2021-12-31 | 17.32 | 13.42 | +344.41% |
| 2020 | 2020-12-31 | 3.90 | — | — |
Maxcyte quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 12.26 | −0.14 | −1.12% |
| Q1 2026 | 2026-03-31 | 12.04 | −0.19 | −1.58% |
| Q4 2025 | 2025-12-31 | 8.30 | −2.59 | −23.77% |
| Q3 2025 | 2025-09-30 | 7.74 | −2.07 | −21.11% |
| Q2 2025 | 2025-06-30 | 12.39 | −1.91 | −13.38% |
| Q1 2025 | 2025-03-31 | 12.23 | −1.03 | −7.74% |
| Q4 2024 | 2024-12-31 | 10.88 | 0.23 | +2.17% |
| Q3 2024 | 2024-09-30 | 9.81 | −3.06 | −23.78% |
| Q2 2024 | 2024-06-30 | 14.31 | −3.61 | −20.15% |
| Q1 2024 | 2024-03-31 | 13.26 | −1.55 | −10.49% |
| Q4 2023 | 2023-12-31 | 10.65 | −5.70 | −34.86% |
| Q3 2023 | 2023-09-30 | 12.87 | −2.18 | −14.46% |
| Q2 2023 | 2023-06-30 | 17.92 | 3.68 | +25.85% |
| Q1 2023 | 2023-03-31 | 14.81 | −2.28 | −13.36% |
| Q4 2022 | 2022-12-31 | 16.35 | −0.96 | −5.56% |
| Q3 2022 | 2022-09-30 | 15.05 | −6.38 | −29.77% |
| Q2 2022 | 2022-06-30 | 14.24 | 7.49 | +110.90% |
| Q1 2022 | 2022-03-31 | 17.09 | — | — |
| Q4 2021 | 2021-12-31 | 17.32 | 13.42 | +344.41% |
| Q3 2021 | 2021-09-30 | 21.43 | — | — |
| Q2 2021 | 2021-06-30 | 6.75 | — | — |
| Q4 2020 | 2020-12-31 | 3.90 | — | — |
Maxcyte current ratio trends
Over the last five fiscal years, Maxcyte's current ratio increased from 3.90 to 8.30, a change of 4.40. The latest reported quarter, Q2 2026, shows 12.26.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maxcyte source filings ↗